Rupniak N M, Carlson E J, Webb J K, Harrison T, Porsolt R D, Roux S, de Felipe C, Hunt S P, Oates B, Wheeldon A
Merck Sharp and Dohme Neuroscience Research Centre, Harlow, Essex, CM20 2QR, UK.
Behav Pharmacol. 2001 Nov;12(6-7):497-508. doi: 10.1097/00008877-200111000-00011.
The phenotype of NK1R-/- mice was compared with that of acute pharmacological blockade of the tachykinin NK1 receptor on sensorimotor function and in assays relevant to depressive illness and anxiety. The dose range for L-760735 and GR205171 that was associated with functional blockade of central NK1 receptors in the target species was established by antagonism of the behavioural effects of intracerebroventricular NK1 agonist challenge in gerbils, mice and rats. The caudal grooming and scratching response to GR73632 was absent in NK1R-/- mice, confirming that the receptor had been genetically ablated. There was no evidence of sedation or motor impairment in NK1R-/- mice or following administration of L-760735 to gerbils, even at doses in excess of those required for central NK1 receptor occupancy. In the resident-intruder and forced swim test, the behaviour of NK1R-/- mice, or animals treated acutely with L-760735 or GR205171, resembled that seen with the clinically used antidepressant drug fluoxetine. However, the effects of GR205171 were not clearly enantioselective in mice. In contrast, although NK1R-/- mice also exhibited an increase in the duration of struggle behaviour in the tail suspension test, this was not observed following pharmacological blockade with L-760735 in gerbils or GR205171 in mice, suggesting that this may reflect a developmental alteration in the knockout mouse. There was no effect of NK1 receptor blockade with L-760735 in guinea-pigs or GR205171 in rats, or deletion of the NK1 receptor in mice, on behaviour in the elevated plus-maze test for anxiolytic activity. These findings extend previous observations on the phenotype of the NK1R-/- mouse and establish a broadly similar profile following acute pharmacological blockade of the receptor. These studies also serve to underscore the limitations of currently available antagonists that are suitable for use in rat and mouse behavioural assays.
将NK1R-/-小鼠的表型与速激肽NK1受体急性药理学阻断对感觉运动功能以及与抑郁症和焦虑症相关检测的表型进行了比较。通过拮抗沙鼠、小鼠和大鼠脑室内NK1激动剂激发的行为效应,确定了与目标物种中枢NK1受体功能阻断相关的L-760735和GR205171的剂量范围。NK1R-/-小鼠对GR73632没有尾部梳理和抓挠反应,证实该受体已通过基因敲除。即使给予超过中枢NK1受体占据所需剂量,NK1R-/-小鼠或给沙鼠施用L-760735后,均未出现镇静或运动障碍的迹象。在定居者-入侵者和强迫游泳试验中,NK1R-/-小鼠或用L-760735或GR205171急性处理的动物的行为,类似于临床使用的抗抑郁药氟西汀的行为。然而,GR205171在小鼠中的作用没有明显的对映体选择性。相比之下,虽然NK1R-/-小鼠在悬尾试验中挣扎行为的持续时间也有所增加,但在用L-760735对沙鼠进行药理学阻断或用GR205171对小鼠进行药理学阻断后未观察到这种情况,这表明这可能反映了基因敲除小鼠的发育改变。在豚鼠中用L-760735阻断NK1受体或在大鼠中用GR205171阻断NK1受体,或在小鼠中缺失NK1受体,对高架十字迷宫抗焦虑活性试验中的行为均无影响。这些发现扩展了先前对NK1R-/-小鼠表型的观察,并在受体急性药理学阻断后建立了大致相似的特征。这些研究还强调了目前适用于大鼠和小鼠行为检测的拮抗剂的局限性。